Illumina, Inc. management check

ILMN · Health Care · Life Sciences Tools & Services · CEO Jacob Thaysen

Filings as of

47
Management score, ranked 443rd of 487 · 53rd of 60 in Health Care3 good · 2 to watch · 2 flaggedStrongest: clean books · Weakest: stable leadership · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$36Peers$122

    What $100 became since fiscal 2022

    016th
    Detail

    $100 invested at the start of fiscal 2022 grew to $36, against $122 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20222025

    Pay actually paid $100 value, each on its own scale

    9686th
    Detail

    Over 4 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.91 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    1.3% of net income

    $11.0m pay · $850.0m net income, FY2025

    0.1%1%3%10%
    4143rd
    Detail

    $11.0m of reported pay in fiscal 2025, against $850.0m of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 2.9 years of pay

    107,770 shares ≈ $31.7m

    0.1y1y5y20y100y

    6 mo: ▲ $0 bought · ▼ $672.0m sold

    3840th
    Detail

    The CEO holds 107,770 shares, directly or through trusts (unvested awards not counted): about 2.9 years of pay. 5 insiders sold $672.0m in the last six months and none bought. 15 of 133 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 151m2025 · 156m

    Diluted shares −0.6% a year; flagged above +2%

    0%10%20%

    Stock pay 6.3% of revenue

    5848th
    Detail

    Diluted shares changed -0.6% a year over the last three fiscal years. Stock-based pay was 6.3% of revenue in the latest year.

  • Flag

    Is leadership stable?

    3 CEOs in the pay table

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Francis deSouza, Charles Dadswell, Jacob Thaysen

    04th
    Detail

    CEOs in the pay table: Francis deSouza, Charles Dadswell, Jacob Thaysen. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 9, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$18.4m$36.7m$1002022202320242025$36$122

Pay tied most to Illumina Revenue

Other key measuresNon-GAAP Earnings Per ShareOperating IncomeOperating MarginRelative Total Shareholder Return

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Francis deSouza, Charles Dadswell, Jacob Thaysen$11.0m$12.8m$3.7m$36$122$850.0m
2024—$14.8m$17.7m$5.4m$37$92−$1.2bn
2023—$14.5m$4.4m$4.5m$38$92−$1.2bn
2022—$14.3m$36.7m$8.0m$103$99$762.0m

Insiders and the CEO's stakeSelling

Chief Executive Officer
Jacob Thaysen
Shares held
107,770
At that filing's price
≈ $31.7m
Latest Form 4
Oct 5, 2026

5 insiders sold $672.0m in the last six months and none bought. 15 of 133 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldKeith A. MeisterDirector$670.9mNov 11, 2026
  • SoldScott D EricksenVP, Chief Accounting Officer · 10b5-1 plan$363kNov 10, 2026
  • SoldScott M DaviesChief Legal Officer · 10b5-1 plan$332kJul 30, 2026
  • SoldPatricia LeckmanSVP, Chief People Officer · 10b5-1 plan$254kJun 5, 2026

Leadership and governance on file

20222023202420252026Leadership 22Votes 6
All 22 filings

Latest shareholder vote results: May 26, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $858.0m returned to owners in buybacks and dividends, and $2.1bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
−$4.4bn−$1.8bn$850.0m20212022202320242025Shares151m157m158m159m156m
Show the figures
Fiscal year20212022202320242025
Revenue$4.5bn$4.6bn$4.5bn$4.4bn$4.3bn
Net income$762.0m−$4.4bn−$1.2bn−$1.2bn$850.0m
Stock-based pay$754.0m$366.0m$380.0m$370.0m$275.0m
Buybacks$0$0$0$116.0m$742.0m
Dividends—————
Diluted shares151m157m158m159m156m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.